Olmesartan medoxomil (CAS 144689-63-4) is an orally active prodrug of the angiotensin II receptor blocker olmesartan. It is a white to off-white powder that is hydrolyzed in vivo to the active AT1 antagonist, used for the treatment of hypertension.
Olmesartan medoxomil
Category:Organic Intermediates
CAS No.:144689-63-4
Product Grade: Pharma grade
Purity / Assay: 99%
Molecular Formula:C₂₉H₃₀N₆O₆
Molecular Weight:558.59
EINECS No.:604-433-1
Synonym(s):Olmesartan medoxomil; Benicar; Olmetec
Olmesartan medoxomil (CAS 144689-63-4) is an orally active prodrug of the angiotensin II receptor blocker olmesartan. It is a white to off-white powder that is hydrolyzed in vivo to the active AT1 antagonist, used for the treatment of hypertension.
1. Used as an API for hypertension treatment through selective AT1 receptor blockade after in vivo hydrolysis. 2. Serves as a prodrug strategy to improve oral bioavailability of the active olmesartan. 3. Applied in cardiovascular pharmaceutical research and fixed-dose combination development. 4. Functions as a reference standard for ARB assay, impurity profiling and bioequivalence studies.
25kg/drum; 200kg/drum
CAS No.: 144689-63-4
Product Name: Olmesartan medoxomil
Purity / Assay:99%
Molecular Formula:C₂₉H₃₀N₆O₆
Molecular Weight:558.59
EINECS No.:604-433-1
Synonym(s):Olmesartan medoxomil; Benicar; Olmetec
For global customers, we provide complete technical documentation to support product evaluation, regulatory compliance and safe handling during transportation and application.